Evidence map›Paper›PMID 42827849›Full record

ReviewFrontiers in nutrition2026

Role of the ketogenic diet in neurodevelopmental disorders: neuroprotection and clinical practice.

Luqiang Sun, Liu Qu, Shuqing Gao, Juan Chen, Pan Wu, Haichuan Wang

Abstract readReview
In one paragraph

Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Luqiang SunThe Third Affiliated Hospital of Chengdu Medical College and Chengdu Pidu District People's Hospital, Chengdu, China.
Liu QuThe Third Affiliated Hospital of Chengdu Medical College and Chengdu Pidu District People's Hospital, Chengdu, China.
Shuqing GaoThe Third Affiliated Hospital of Chengdu Medical College and Chengdu Pidu District People's Hospital, Chengdu, China.
Juan ChenThe Third Affiliated Hospital of Chengdu Medical College and Chengdu Pidu District People's Hospital, Chengdu, China.
Pan WuThe Third Affiliated Hospital of Chengdu Medical College and Chengdu Pidu District People's Hospital, Chengdu, China.
Haichuan WangSichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodevelopmental disorders (NDDs), such as autism spectrum disorder (ASD), occur early in life and affect cognitive and behavioral health and motor development. While hereditary factors contribute to the development of ASD, recent research has shown that environmental factors, notably nutritional factors, play important roles in determining the severity and expression of symptoms. The ketogenic diet (KD), a high-fat, low-carbohydrate dietary strategy, has well-established therapeutic significance, particularly in the management of epilepsy. Currently, the KD has recently gained popularity beyond therapeutic treatment, becoming popular as a general health and lifestyle option for healthy people. However, despite its long history, the effects of KD consumption on the development of NDDs are uncertain. This review highlights current literature on the effects of maternal KD on child brain development and NDD development, emphasizing the potential relevance of the KD in treating NDDs. We discuss the therapeutic implications of KD consumption and highlight the known effects of maternal KD on NDD development in children, potentially improving our understanding of NDD treatment. Assessments of the safety of KD and its long-term effects on the developing nervous system should be prioritized in future studies to help evaluate the feasibility, safety, and implementation of the KD in treating NDDs.

Indexed as

attention deficit hyperactivity disorderautism spectrum disorderketogenic dietneurodevelopmental disordersneuroprotection

Identifiers

PMID42827849
PMCPMC13631953

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.